RB1 and pancreatic adenocarcinoma: Indeed, we found in our signature the transcript RB1-201 and, according to the CIViC database, there is preclinical evidence of drugs (e.g. doxorubicin, gemcitabine, mitomycin and fluorouracil) to be used in PAAD patients overexpressing RB1 gene (77).